Sichuan Goldstone Asia Pharmaceutical Inc. (SHE:300434)
China flag China · Delayed Price · Currency is CNY
9.84
-0.22 (-2.19%)
Jun 2, 2026, 3:04 PM CST

Revenue by Segment

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Pharmaceutical Manufacturing Industry
866.90M914.52M1.09B1.09B819.01M
Pharmaceutical Manufacturing Industry Growth
-5.21%-16.01%0.18%32.71%45.52%
Machinery manufacturing industry
145.15M155.25M86.29M113.82M188.81M
Machinery manufacturing industry Growth
-6.51%79.92%-24.19%-39.72%10.16%
Real Estate Leasing and Management Industry
30.02M32.58M34.09M41.88M45.68M
Real Estate Leasing and Management Industry Growth
-7.85%-4.45%-18.60%-8.32%5.99%
Inter-Department Offsetting
-3.67M----
Total
1.04B1.10B1.21B1.24B1.05B
Total Growth
-5.80%-8.84%-2.69%17.95%35.53%

Revenue by Geography

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2023FY 2022FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Eastern China
537.45M521.96M561.44M623.61M497.54M
Eastern China Growth
2.97%-7.03%-9.97%25.34%31.13%
Southwest
88.11M151.91M135.91M134.26M136.59M
Southwest Growth
-41.99%11.77%1.23%-1.70%50.86%
North China
108.58M120.71M154.85M141.48M129.55M
North China Growth
-10.05%-22.05%9.45%9.21%73.48%
Central China
93.70M116.79M137.56M128.86M96.82M
Central China Growth
-19.77%-15.10%6.75%33.09%20.34%
Northwest
92.22M72.93M105.42M83.30M95.65M
Northwest Growth
26.46%-30.83%26.55%-12.91%53.14%
South China
51.05M49.46M60.30M84.52M51.20M
South China Growth
3.22%-17.97%-28.65%65.08%32.98%
Northeast
32.22M29.06M49.26M34.84M41.61M
Northeast Growth
10.90%-41.01%41.41%-16.28%22.88%
Overseas
35.05M39.54M4.46M11.74M4.55M
Overseas Growth
-11.36%786.94%-62.02%158.15%-73.83%
Total
1.04B1.10B1.21B1.24B1.05B
Total Growth
-5.80%-8.84%-2.69%17.95%35.53%
Source: S&P Global Market Intelligence.